Simplify Asset Management Inc. Has $2.28 Million Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Simplify Asset Management Inc. raised its stake in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 67.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 9,637 shares of the medical research company's stock after acquiring an additional 3,894 shares during the quarter. Simplify Asset Management Inc.'s holdings in IQVIA were worth $2,284,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. PGGM Investments raised its holdings in shares of IQVIA by 55.8% in the second quarter. PGGM Investments now owns 12,073 shares of the medical research company's stock valued at $2,553,000 after buying an additional 4,326 shares during the last quarter. Quadrature Capital Ltd bought a new position in shares of IQVIA in the first quarter valued at about $3,365,000. Raymond James & Associates raised its holdings in shares of IQVIA by 0.7% in the second quarter. Raymond James & Associates now owns 800,374 shares of the medical research company's stock valued at $169,231,000 after buying an additional 5,417 shares during the last quarter. UniSuper Management Pty Ltd raised its holdings in shares of IQVIA by 253.0% in the first quarter. UniSuper Management Pty Ltd now owns 6,029 shares of the medical research company's stock valued at $1,525,000 after buying an additional 4,321 shares during the last quarter. Finally, Sei Investments Co. raised its holdings in shares of IQVIA by 4.8% in the first quarter. Sei Investments Co. now owns 57,887 shares of the medical research company's stock valued at $14,638,000 after buying an additional 2,638 shares during the last quarter. 89.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft cut their price target on IQVIA from $270.00 to $265.00 and set a "buy" rating for the company in a report on Friday, November 1st. Truist Financial lowered their price objective on IQVIA from $286.00 to $265.00 and set a "buy" rating for the company in a research report on Monday, November 4th. Barclays lowered their price objective on IQVIA from $260.00 to $255.00 and set an "overweight" rating for the company in a research report on Friday, November 1st. JPMorgan Chase & Co. lowered their price objective on IQVIA from $279.00 to $240.00 and set an "overweight" rating for the company in a research report on Tuesday, November 5th. Finally, The Goldman Sachs Group decreased their target price on IQVIA from $280.00 to $250.00 and set a "buy" rating for the company in a research report on Friday, November 1st. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $259.13.

IQVIA Stock Performance

Shares of IQV stock traded down $10.31 during midday trading on Friday, hitting $192.63. 4,579,132 shares of the company were exchanged, compared to its average volume of 1,143,450. The firm has a market capitalization of $34.96 billion, a P/E ratio of 25.62, a PEG ratio of 2.17 and a beta of 1.51. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. IQVIA Holdings Inc. has a 52 week low of $189.63 and a 52 week high of $261.73. The firm's 50 day moving average price is $227.96 and its two-hundred day moving average price is $228.59.

Insider Transactions at IQVIA

In related news, insider Eric Sherbet sold 1,300 shares of the business's stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total value of $320,229.00. Following the completion of the transaction, the insider now owns 19,536 shares of the company's stock, valued at $4,812,302.88. The trade was a 6.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.60% of the company's stock.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.